Filing Details

Accession Number:
0001822629-24-000006
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-08 19:25:12
Reporting Period:
2024-03-06
Accepted Time:
2024-03-08 19:25:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1023024 Ani Pharmaceuticals Inc ANIP Pharmaceutical Preparations (2834) 582301143
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1822629 Nikhil Lalwani C/O Ani Pharmaceuticals, Inc.
210 Main Street West
Baudette MN 56623
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-03-06 28,965 $65.52 444,981 No 4 S Direct
Common Stock Disposition 2024-03-07 17,060 $66.71 427,921 No 4 F Direct
Common Stock Disposition 2024-03-08 16,292 $67.13 411,629 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 F Direct
No 4 S Direct
Footnotes
  1. The shares were sold in multiple trades at prices ranging from $65.00 to $66.01. The price reported above reflects the weighted average sales price.
  2. Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 33,352 shares of restricted stock, the grant of which was previously reported.
  3. The shares were sold in multiple trades at prices ranging from $66.42 to $67.74. The price reported above reflects the weighted average sales price.